ZMAY vs. DOCT
ZMAY (Innovator Equity Defined Protection ETF - 1 Yr May) and DOCT (FT Vest U.S. Equity Deep Buffer ETF - October) are both Defined Outcome funds. ZMAY is actively managed, while DOCT is passively managed. Over the past year, ZMAY returned 5.93% vs 16.67% for DOCT. A 0.67 correlation means they provide meaningful diversification when combined. ZMAY charges 0.79%/yr vs 0.85%/yr for DOCT.
Performance
ZMAY vs. DOCT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ZMAY achieves a 2.24% return, which is significantly lower than DOCT's 5.28% return.
ZMAY
- 1D
- 0.04%
- 1M
- 0.62%
- YTD
- 2.24%
- 6M
- 2.79%
- 1Y
- 5.93%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
DOCT
- 1D
- 0.21%
- 1M
- 1.78%
- YTD
- 5.28%
- 6M
- 5.74%
- 1Y
- 16.67%
- 3Y*
- 11.10%
- 5Y*
- 7.78%
- 10Y*
- —
ZMAY vs. DOCT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
ZMAY Innovator Equity Defined Protection ETF - 1 Yr May | 2.24% | 4.67% |
DOCT FT Vest U.S. Equity Deep Buffer ETF - October | 5.28% | 15.09% |
Correlation
The correlation between ZMAY and DOCT is 0.66, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.66 |
Correlation (All Time) Calculated using the full available price history since May 2, 2025 | 0.67 |
The correlation between ZMAY and DOCT has been stable across timeframes, ranging from 0.66 to 0.67 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ZMAY vs. DOCT — Risk / Return Rank
ZMAY
DOCT
ZMAY vs. DOCT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Innovator Equity Defined Protection ETF - 1 Yr May (ZMAY) and FT Vest U.S. Equity Deep Buffer ETF - October (DOCT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ZMAY | DOCT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.30 | ||
| Sortino ratioReturn per unit of downside risk | +3.09 | ||
| Omega ratioGain probability vs. loss probability | 1.95 | 1.56 | +0.40 |
| Calmar ratioReturn relative to maximum drawdown | 15.23 | 3.86 | +11.37 |
| Martin ratioReturn relative to average drawdown | 70.67 | 19.42 | +51.25 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ZMAY | DOCT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 4.11 | 2.81 | +1.30 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 1.07 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 4.26 | 0.53 | +3.73 |
Drawdowns
ZMAY vs. DOCT - Drawdown Comparison
The maximum ZMAY drawdown since its inception was -0.39%, smaller than the maximum DOCT drawdown of -9.92%. Use the drawdown chart below to compare losses from any high point for ZMAY and DOCT.
Loading charts...
Drawdown Indicators
| ZMAY | DOCT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -0.39% | -9.92% | +9.53% |
Max Drawdown (1Y)Largest decline over 1 year | -0.39% | -4.34% | +3.95% |
Max Drawdown (3Y)Largest decline over 3 years | — | -9.92% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -9.92% | — |
Current DrawdownCurrent decline from peak | -0.02% | 0.00% | -0.02% |
Average DrawdownAverage peak-to-trough decline | -0.05% | -1.54% | +1.49% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 0.08% | 0.86% | -0.78% |
Volatility
ZMAY vs. DOCT - Volatility Comparison
The current volatility for Innovator Equity Defined Protection ETF - 1 Yr May (ZMAY) is 0.50%, while FT Vest U.S. Equity Deep Buffer ETF - October (DOCT) has a volatility of 0.82%. This indicates that ZMAY experiences smaller price fluctuations and is considered to be less risky than DOCT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ZMAY | DOCT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 0.50% | 0.82% | -0.32% |
Volatility (6M)Calculated over the trailing 6-month period | 1.06% | 4.40% | -3.34% |
Volatility (1Y)Calculated over the trailing 1-year period | 1.45% | 5.96% | -4.51% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 1.52% | 7.33% | -5.81% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 1.52% | 48.56% | -47.04% |
ZMAY vs. DOCT - Expense Ratio Comparison
ZMAY has a 0.79% expense ratio, which is lower than DOCT's 0.85% expense ratio.
Dividends
ZMAY vs. DOCT - Dividend Comparison
Neither ZMAY nor DOCT has paid dividends to shareholders.
Frequently Asked Questions
ZMAY and DOCT have a correlation of 0.66, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
DOCT has higher volatility (0.82%) compared to ZMAY (0.50%). In terms of maximum drawdown, ZMAY dropped -0.39% vs DOCT's -9.92%.
On 1-year performance, DOCT leads with 16.67% vs 5.93% for ZMAY. On fees, ZMAY is cheaper at 0.79% per year. On volatility, ZMAY has been the lower-risk option at 0.50%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, DOCT has performed better with a 16.67% return vs 5.93%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
ZMAY is cheaper with a 0.79% expense ratio, compared with 0.85% for DOCT.
ZMAY and DOCT have nearly identical dividend yields, around 0.00%.
They also come from different issuers: Innovator and FT Vest. Their fees differ too: 0.79% for ZMAY and 0.85% for DOCT.
ZMAY currently has the higher Sharpe Ratio (4.11 vs 2.81), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ZMAY and DOCT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer